Wells Fargo & Company MN Grows Stock Position in Maximus, Inc. (NYSE:MMS)

Wells Fargo & Company MN lifted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 36.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,148 shares of the health services provider's stock after buying an additional 9,055 shares during the quarter. Wells Fargo & Company MN owned about 0.06% of Maximus worth $2,549,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in MMS. UMB Bank n.a. grew its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares in the last quarter. V Square Quantitative Management LLC boosted its position in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares in the last quarter. Hillsdale Investment Management Inc. grew its position in Maximus by 0.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after acquiring an additional 230 shares during the last quarter. Bridge City Capital LLC increased its holdings in Maximus by 0.9% in the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock worth $2,128,000 after purchasing an additional 254 shares in the last quarter. Finally, Inspire Advisors LLC raised its position in Maximus by 3.1% in the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after purchasing an additional 258 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have weighed in on MMS. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Maximus Trading Down 0.6 %

Shares of Maximus stock traded down $0.41 during midday trading on Wednesday, reaching $66.98. The company had a trading volume of 539,862 shares, compared to its average volume of 555,960. The firm has a market cap of $3.79 billion, a PE ratio of 14.40 and a beta of 0.68. The stock has a fifty day moving average price of $67.66 and a 200 day moving average price of $74.14. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. Maximus's payout ratio is currently 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.